Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by JANSSEN, M.
Right arrow Articles by VANDENBROUCKE, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JANSSEN, M.
Right arrow Articles by VANDENBROUCKE, J. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 British Society for Rheumatology

research-article

A GASTROSCOPIC STUDY OF THE PREDICTIVE VALUE OF RISK FACTORS FOR NON-STEROIDAL ANTI-INFLAMMATORY DRUG-ASSOCIATED ULCER DISEASE IN RHEUMATOID ARTHRITIS PATIENTS

M. JANSSEN*, B. A. C. DIJKMANS*, C. B. H. W. LAMERS{dagger}, A. H. ZWINDERMAN{ddagger} and J. P. VANDENBROUCKE§

*Department of Rheumatology, University Hospital Leiden, The Netherlands
{dagger}Department of Gastroenterology, University Hospital Leiden, The Netherlands
{ddagger}Department of Medical Statistics, University Hospital Leiden, The Netherlands
§Department of Clinical Epidemiology, University Hospital Leiden, The Netherlands

Peptic ulcer disease (PUD) in RA patients is associated with NSAID use. This study aimed to validate the predictive value of presumed risk factors for NSAID-associated PUD in a prospective gastroscopic study in RA patients. Eighty-one NSAID using RA patients were prospectively divided into four presumed risk groups according to Helicobacter pylori status and history of PUD. As additional risk factors the following were analysed: upper gastrointestinal GI complaints; disability; daily dose of NSAID and antral gastritis. The presence of PUD in the four risk groups did not differ. Additionally it was found that a history of PUD was predictive for current PUD [odds ratio (OR) 3.9; 95% CI 1.1–14]. H. pylori status was not predictive. Transformation from one ulcer type to another was rare. NSAID dose was not a risk factor, while disability was of borderline importance (OR 2.1; 95% CI 1–4.8). Current upper GI complaints were bad predictors. PUD only occurred with a concomitant antral gastritis. A history of PUD, disability and antral gastritis were the most important predictors for current PUD. When an ulcer relapsed it was of the same ulcer type as had been present earlier. This may have practical implications for prophylaxis enabling stratification by previous ulcer type.

KEY WORDS: Non-steroidal anti-inflammatory drugs, Peptic ulcer disease, H. pylori, Gastritis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch Intern MedHome page
D. Yocum, R. Fleischmann, P. Dalgin, J. Caldwell, D. Hall, P. Roszko, and for the Meloxicam Osteoarthritis Investigators
Safety and Efficacy of Meloxicam in the Treatment of Osteoarthritis: A 12-Week, Double-blind, Multiple-Dose, Placebo-Controlled Trial
Arch Intern Med, October 23, 2000; 160(19): 2947 - 2954.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.